AstraZeneca (AZN)

Featured here, the Balance Sheet for AstraZeneca, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).

122.90 +0.10 (+0.08%)

16:39:00 Delayed Data EUR Disclaimer

AZN Balance Sheet

Total Current Assets

Name	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Total Current Assets	22,593	20,224	20,917	22,647	26,244
Cash and Short Term Investments	6,243	4,522	4,887	5,823	6,398
Cash	-	-	-	-	-
Cash & Equivalents	6,166	4,458	4,817	5,762	6,329
Short Term Investments	64	64	70	61	53
Total Receivables, Net	11,252	10,061	9,612	9,050	8,795
Accounts Receivables - Trade, Net	10,521	9,336	8,908	8,683	6,031
Total Inventory	4,699	5,078	6,220	7,624	8,983
Prepaid Expenses	1,512	-	-	-	-
Other Current Assets, Total	399	563	198	150	556
Total Assets	96,483	94,185	96,579	100,273	105,363
Property/Plant/Equipment, Total - Net	9,449	9,227	9,627	10,015	10,171
Property/Plant/Equipment, Total - Gross	18,495	-	-	-	-
Accumulated Depreciation, Total	-8,324	-	-	-	-
Goodwill, Net	19,820	19,707	19,821	19,963	19,997
Intangibles, Net	39,307	39,585	39,900	41,265	42,387
Long Term Investments	1,142	1,102	1,180	1,237	1,262
Note Receivable - Long Term	731	725	704	367	2,764
Other Long Term Assets, Total	909	904	994	951	972
Other Assets, Total	-1,485	-920	1,016	2,980	5,143
Total Current Liabilities	26,293	24,850	21,815	22,740	22,594
Accounts Payable	2,550	16,842	16,983	17,040	2,824
Payable/Accrued	-	-	-	-	-
Accrued Expenses	12,358	-	-	-	-
Notes Payable/Short Term Debt	350	743	747	805	411
Current Port. of LT Debt/Capital Leases	1,188	5,795	2,563	2,348	2,481
Other Current liabilities, Total	3,814	1,470	1,522	2,547	4,520
Total Liabilities	59,425	59,031	60,628	63,914	66,076
Total Long Term Debt	24,633	24,737	28,078	29,592	30,471
Long Term Debt	23,908	24,069	27,393	28,868	29,717
Capital Lease Obligations	725	668	685	724	754
Deferred Income Tax	2,944	3,479	5,275	5,626	6,206
Minority Interest	21	20	19	19	19
Other Liabilities, Total	-4,057	846	386	854	2,085
Total Equity	37,058	35,154	35,951	36,359	39,287
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	387	387	387	387	387
Additional Paid-In Capital	35,155	35,137	35,134	35,131	35,126
Retained Earnings (Accumulated Deficit)	-574	-2,471	-1,657	-1,228	3,644
Treasury Stock - Common	-	-	-	-	-
ESOP Debt Guarantee	-	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-	-
Other Equity, Total	-1,604	2,101	2,087	2,069	130
Total Liabilities & Shareholders' Equity	96,483	94,185	96,579	100,273	105,363
Total Common Shares Outstanding	1,549.80	1,548	1,549	1,548	1,549.40
Total Preferred Shares Outstanding	-	-	-	-	-

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.